Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 684-689, 2011.
Article Dans Chinois | WPRIM | ID: wpr-265830

Résumé

<p><b>OBJECTIVE</b>To find the optimal proportion of Composite Fructus Psoralea and Fructus Cnidii (CFPC) for inhibiting the bone metastasis of breast cancer by way of exploring its acting mechanism viewing from OPG/RANKL/RANK system.</p><p><b>METHODS</b>The human bone metastasis of breast cancer model was established by injecting tumor cells of MDA-MB-231BO cell line into the left cardiac ventricle of nude mice. The modeled mice were randomly divided into seven groups: the blank group administered with normal saline by gastrogavage, the positive control group with zoledronic acid via peritoneal injection, and the 5 tested group with CFPC in different proportions of Fructus Psoralea and Fructus Cnidii, i.e., (A, 4:0; B, 3:1; C, 1:1; D, 1:3, and E 0:4), given by gastric infusion. The treatment started from 1 week after modeling and lasted for six weeks. By the end of the experiment, the metastatic foci in bone were imaged by radionuclide tracing method and X-ray photograph, and separated for detecting gene and protein expressions of osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB ligand (RANKL), interleukin-8 (IL-8), parathyroid hormone-related protein (PTHrP), macrophage colony stimulating factor (MCSF) by Real-time PCR and Western blot respectively.</p><p><b>RESULTS</b>Inhibition of bone metastasis gene was displayed to some extent in all the tested groups treated with CFPC, showing an increased level of OPG mRNA expression (It was 60.343 +/- 6.274 in the tested group C), and decreased mRNA expressions of IL-8, PTHrP, MCSF, RANKL (218.010 +/- 12.802, 232.399 +/- 14.354, 319.831 +/- 5.322, and 195.701 +/- 4. 862, respectively in the tested group C). The optimal effect was shown in the tested group C, showing significant difference to that in the blank group (P < 0.01). Meanwhile, the OPG in the bone metastatic foci could be up-regulated and protein expressions of RANKL/IL-8/PTHrP/MCSF down-regulated in all the tested groups. The optimal effect was shown in the tested group C, with significant difference from those of the normal saline group.</p><p><b>CONCLUSION</b>CFPC could inhibit the bone metastasis of breast cancer through activating OPG/RANKL/RANK pathway. Among different proportions of Fructus Psoralea and Fructus Cnidii, 1:1 was the best one.</p>


Sujets)
Animaux , Femelle , Souris , Tumeurs osseuses , Métabolisme , Anatomopathologie , Tumeurs du sein , Métabolisme , Anatomopathologie , Lignée cellulaire tumorale , Coumarines , Pharmacologie , Psoralène , Pharmacologie , Interleukine-8 , Métabolisme , Facteur de stimulation des colonies de macrophages , Métabolisme , Souris de lignée BALB C , Souris nude , Métastase tumorale , Ostéoprotégérine , Métabolisme , Protéine apparentée à l'hormone parathyroïdienne , Métabolisme , Ligand de RANK , Métabolisme , Récepteur activateur du facteur nucléaire Kappa B , Métabolisme
SÉLECTION CITATIONS
Détails de la recherche